Back to results
US 2010/0168116 A1Published application
3,6-substituted imidazol[1,2-b]pyridazine analogs for treating allergic and inflammatory diseases
AssigneeAlcon Inc.
InventorsMark R. Hellberg, Steven T. Miller, Andrew Rusinko
Life of this patent
Estimating the term…
Abstract
Methods for treating an allergic or inflammatory disease or other Syk-mediated disease or Syk-mediated condition characterized by administering a composition which contains a therapeutically effective amount of a 3,6-substituted imidazol[1,2-b]pyridazine compound.
Claims14
A method for treating an allergic or inflammatory disease or other Syk-mediated disease or Syk-mediated condition in a patient which comprises administering to the patient a composition comprising a therapeutically effective amount of a compound of the formula:
- wherein:
- A=aryl or heteroaryl optionally substituted by F, Cl, Br, C1-C6 alkyl, OR2, or OCF3;
- R1═H, C1-C6 alkyl, heterocyclyl, or (CH2)n—X;
- n=1-4;
- X=aryl, heteroaryl, OR5 or NR3R4;
- and
- R2, R3, R4, R5 independently=H or C1-C6 alkyl;
- provided that the allergic or inflammatory disease or other Syk-mediated disease or Syk-mediated condition is selected from the group consisting of nasal allergic disorders;
- rhinitis;
- and sinusitis.
7 more elements
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.